| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.2 | 4e-06 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.23 | 4e-05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.087 | 0.05 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.093 | 0.05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.093 | 0.05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.083 | 0.08 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.087 | 0.09 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.059 | 0.2 |